(To be Published in the Gazette of India Extraordinary Part-II, Section - 3, Sub-Section (ii))

Government of India Ministry of Commerce & Industry Department of Commerce Directorate General of Foreign Trade Udyog Bhawan New Delhi

Notification No. 01/2015-2020 New Delhi, Dated: 11** April, 2021

Subject: Amendment in Export Policy of Injection Remdesivir and Remdesivir API.

S.O. (E) In exercise of powers conferred by Section 3 of the Foreign Trade (Development & Regulation) Act, 1992 (No. 22 of 1992), as amended, read with Para 1.02 and 2.01 of the Foreign Trade Policy, 2015-20, the Central Government hereby makes the following amendment in Schedule 2 of the ITCHS Export policy related to export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API):

==> picture [454 x 84] intentionally omitted <==

----- Start of picture text -----<br> ITC HS Description Present Policy| Revised<br>Codes Policy<br>Injection Remdesivir and<br>Ex 293499 |Remdesivir Active<br>207AA |Ex 300490 |Pharmaceutical Prohibited<br>Ingredients(API)<br>----- End of picture text -----<br>

2. The provision under Para 1.05 of the Foreign Trade Policy (FTP) 2015-20 regarding transitional arrangement is not applicable for this notification.

3. Effect of this Notification:

The export of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) falling under the ITCHS Codes specified above or falling under any other HS Code has been prohibited, with immediate effect.

U\ oO oul (Amit Yadavy> Director General of Foreign Trade Ex-Officio Additional Secretary, Government of India E-mail: dgft@nic.in

(Issued from File No. 01/91/180/24/AM22/EC/E-27724)